MUCORMYCOSIS
Clinical trials for MUCORMYCOSIS explained in plain language.
Never miss a new study
Get alerted when new MUCORMYCOSIS trials appear
Sign up with your email to follow new studies for MUCORMYCOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Korean study monitors fungal drug safety
Disease control CompletedThis study looked at how safe and effective the drug Cresemba is for adults with serious fungal infections like invasive aspergillosis or mucormycosis. It involved 94 people in Korea who were already prescribed the drug. The main goal was to track any side effects and see if the …
Matched conditions: MUCORMYCOSIS
Sponsor: Pfizer • Aim: Disease control
Last updated May 11, 2026 20:48 UTC
-
COVID-19 era shifted fungal infection patterns in transplant patients, study finds
Knowledge-focused CompletedThis study looked back at medical records of 60 adults with blood cancers who had a stem cell transplant and later developed a rare fungal infection called mucormycosis. Researchers compared cases before and during the COVID-19 pandemic to see how the virus, new diagnostic tools,…
Matched conditions: MUCORMYCOSIS
Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Knowledge-focused
Last updated May 17, 2026 03:29 UTC
-
Real-World data reveals Isavuconazole's effectiveness against deadly fungal infections
Knowledge-focused CompletedThis study reviewed medical charts of 307 adults in five European countries who were treated with isavuconazole for invasive aspergillosis or mucormycosis. Researchers tracked how well the drug worked, its safety, and how it was used in routine care. The goal was to understand re…
Matched conditions: MUCORMYCOSIS
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated May 07, 2026 18:41 UTC